Bambara R A, Crute J J, Wahl A F
Cancer Invest. 1985;3(5):473-9. doi: 10.3109/07357908509039809.
The most well established fact concerning Ap4A metabolism is that the concentration of this compound is cell cycle and cell proliferation dependent. An additional intriguing fact is that Ap4A can stimulate DNA synthesis in cell extracts, and when injected into living cells. In view of these facts, it is not surprising that Ap4A has been postulated to regulate the initiation of DNA replication. However, in our opinion, experimental efforts designed to test this hypothesis do not conclusively link Ap4A to DNA replication. Work on the mechanism of stimulation of DNA synthesis in vitro indicates that Ap4A and a variety of adenylated nucleotides increase DNA synthetic rates by acting as primers. Thus far there is no evidence that this primer function plays a role in the initiation of normal DNA replication in vivo, or that Ap4A is unique in this capacity to stimulate initiation processes. Additional experiments have shown an association of partially purified DNA alpha polymerase with both tryptophanyl-tRNA synthetase and a protein capable of binding Ap4A. The Ap4A-binding protein appears to be necessary for Ap4A to assume the correct conformation for priming, since physiological levels of Ap4A are not stimulatory for highly purified DNA alpha polymerase. The relevance of tRNA synthetases to the regulation hypothesis is their ability to produce Ap4A. Ironically, mammalian tryptophanyl-tRNA synthetase does not appear to have this capacity. Furthermore, the association of alpha polymerase with either Ap4A-binding protein or tryptophanyl-tRNA synthetase in vivo has not been conclusively demonstrated. Although Ap4A has been postulated to regulate many phenomena in eukaryotes and bacteria, such as entry into S phase and the response to oxygen deprivation, the links between Ap4A and these processes are still only circumstantial. It is tempting to extrapolate from the alarmone and stringent responses of bacteria to other systems, but these phenomena are not known to occur in eukaryotic cells. Similar deprivation and inhibition experiments in mammalian cells have been shown to stop growth at a synchronous position in cell cycle, and the Ap4A concentration has been found simply to vary accordingly. The addition or depletion of Ap4A from intracellular pools has not been shown to alter cell cycle. Therefore, while the speculation concerning the role of Ap4A in vivo is a good source of future experiments, at this point its role as an important regulatory compound is far from demonstrated.
关于Ap4A代谢,最确凿的事实是该化合物的浓度依赖于细胞周期和细胞增殖。另一个有趣的事实是,Ap4A能够刺激细胞提取物中的DNA合成,并且在注入活细胞时也能起到这种作用。鉴于这些事实,推测Ap4A可调节DNA复制的起始并不奇怪。然而,在我们看来,旨在验证这一假设的实验并未确凿地将Ap4A与DNA复制联系起来。体外DNA合成刺激机制的研究表明,Ap4A和多种腺苷酸化核苷酸通过充当引物来提高DNA合成速率。到目前为止,尚无证据表明这种引物功能在体内正常DNA复制起始过程中发挥作用,也没有证据表明Ap4A在刺激起始过程的这种能力方面具有独特性。其他实验表明,部分纯化的DNAα聚合酶与色氨酰 - tRNA合成酶以及一种能够结合Ap4A的蛋白质存在关联。Ap4A结合蛋白似乎是Ap4A呈现正确引物构象所必需的,因为生理水平的Ap4A对高度纯化的DNAα聚合酶并无刺激作用。tRNA合成酶与调节假设的相关性在于它们产生Ap4A的能力。具有讽刺意味的是,哺乳动物色氨酰 - tRNA合成酶似乎不具备这种能力。此外,α聚合酶与Ap4A结合蛋白或色氨酰 - tRNA合成酶在体内的关联尚未得到确凿证实。尽管推测Ap4A可调节真核生物和细菌中的许多现象,如进入S期以及对缺氧的反应,但Ap4A与这些过程之间的联系仍只是间接的。从细菌的警报素和严谨反应推断到其他系统很诱人,但这些现象在真核细胞中并不为人所知。在哺乳动物细胞中进行的类似剥夺和抑制实验表明,细胞生长在细胞周期的同步位置停止,并且发现Ap4A浓度仅相应变化。细胞内池中的Ap4A添加或耗尽并未显示会改变细胞周期。因此,虽然关于Ap4A在体内作用的推测是未来实验的一个良好来源,但目前其作为重要调节化合物的作用远未得到证实。